x |
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
o |
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Nevada |
52-2088326 |
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
Large accelerated filer o
|
Accelerated filer o
|
Non-accelerated filer o (Do not check if a smaller reporting company) |
Smaller reporting company x |
Page |
|||
PART I |
|||
ITEM 1. Financial Statements |
|||
Condensed consolidated balance sheets |
3 | ||
Condensed consolidated statements of operations (unaudited) |
4 | ||
Condensed consolidated statement of changes in stockholders’ deficiency (unaudited) |
5 | ||
Condensed consolidated statements of cash flows (unaudited) |
14 | ||
Notes to condensed consolidated financial statements (unaudited) |
16 | ||
ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |
28 | ||
ITEM 3. Quantitative and Qualitative Disclosure About Market Risk |
37 | ||
ITEM 4. Controls and Procedures |
37 | ||
PART II |
|||
ITEM 1. Legal Proceedings |
39 | ||
ITEM 1A. Risk Factors |
40 | ||
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds |
40 | ||
ITEM 3. Defaults Upon Senior Securities |
41 | ||
ITEM 4. Submission of Matters to a Vote of Security Holders |
41 | ||
ITEM 5. Other Information |
42 | ||
ITEM 6. Exhibits |
42 | ||
SIGNATURES |
43 | ||
EXHIBIT INDEX |
44 | ||
EXHIBIT 31.1 |
|||
EXHIBIT 31.2 |
|||
EXHIBIT 32 |
June 30, 2009
(unaudited) |
December 31,
2008 |
|||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash |
$ |
5,195 |
$ |
59,346 |
||||
Other current assets |
23,047 |
33,275 |
||||||
Total current assets |
28,242 |
92,621 |
||||||
Property and Equipment, net of accumulated depreciation and amortization of $127,969 and $111,193, respectively |
115,193 |
131,969 |
||||||
Other assets |
11,020 |
11,250 |
||||||
Total assets |
$ |
154,455 |
$ |
235,840 |
||||
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY |
||||||||
Current liabilities |
||||||||
Accounts payable-related parties |
$ |
156,227 |
$ |
93,003 |
||||
Accounts payable-License Agreements |
840,750 |
716,500 |
||||||
Accounts payable-other |
501,310 |
384,467 |
||||||
Accrued expenses |
1,022,976 |
803,795 |
||||||
Accrued professional fees |
431,242 |
390,535 |
||||||
Loans payable-related parties and shareholders |
162,341 |
78,280 |
||||||
Convertible debentures, net-related parties |
39,782 |
12,466 |
||||||
Convertible debentures, net-others |
847,253 |
290,659 |
||||||
Total current liabilities |
4,001,881 |
2,769,705 |
||||||
Commitments and contingencies |
||||||||
Stockholders’ deficiency |
||||||||
Common stock, $.001 par value: 200,000,000 shares authorized, 65,508,160 and 62,940,891 shares issued and outstanding at June 30, 2009 and December 31, 2008, respectively |
65,508 |
62,941 |
||||||
Common stock to be issued (99,200 shares at June 30, 2009 and 97,059 shares at December 31, 2008 respectively) |
33,750 |
16,500 |
||||||
Additional paid-in capital |
41,328,142 |
40,129,758 |
||||||
Deficit accumulated during the development stage |
(45,274,826) |
(42,743,064 |
) | |||||
Total stockholders’ deficiency |
(3,847,426) |
(2,533,865 |
) | |||||
Total liabilities and stockholders’ deficiency |
$ |
154,455 |
$ |
235,840 |
Three months ended
June 30, |
Six months ended
June 30, |
For the Period From
February 18, 1998 (Date of Inception) through |
||||||||||||||||||
2009 |
2008 |
2009 |
2008 |
June 30, 2009 |
||||||||||||||||
Net sales |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
69,000 |
||||||||||
Cost of goods sold |
- |
- |
- |
- |
24,120 |
|||||||||||||||
Gross profit |
- |
- |
- |
- |
44,880 |
|||||||||||||||
Operating expenses |
594,604 |
519,860 |
1,435,422 |
1,280,002 |
31,362,362 |
|||||||||||||||
Research and development expenses |
15,220 |
62,692 |
262,060 |
322,362 |
5,720,653 |
|||||||||||||||
Non-cash patent settlement costs |
- |
- |
- |
- |
1,610,066 |
|||||||||||||||
Loss before other income (expense) |
(609,824 |
) |
(582,552 |
) |
(1,697,482) |
(1,602,364 |
) |
(38,648,201 |
) | |||||||||||
Other income (expense) |
||||||||||||||||||||
Other income |
- |
11 |
- |
563 |
(1,140 |
) | ||||||||||||||
Interest income |
- |
- |
- |
2 |
16,342 |
|||||||||||||||
Interest expense |
(369,720 |
) |
(161,556 |
) |
(834,280) |
(488,559 |
) |
(6,788,586 |
) | |||||||||||
Loss on sale of equipment |
- |
- |
- |
(9,683 |
) |
(14,426 |
) | |||||||||||||
Settlement of debt due Morale/Matthews |
- |
- |
- |
(927,903 |
) |
(927,903 |
) | |||||||||||||
Settlement of litigation and debt |
- |
52,070 |
- |
52,070 |
1,089,088 |
|||||||||||||||
Net loss |
$ |
(979,544 |
) |
$ |
(692,027 |
) |
$ |
(2,531,762) |
$ |
(2,975,874 |
) |
$ |
(45,274,826 |
) | ||||||
Net loss per share, basic and diluted |
$ |
(0.02 |
) |
$ |
(0.02 |
) |
$ |
(0.04) |
$ |
(0.06 |
) |
|||||||||
Weighted average shares outstanding, basic and diluted |
65,037,789 |
44,938,165 |
64,504,305 |
46,979,175 |
Price per |
Common Stock |
Common
Stock
to be |
Additional
Paid-in |
Deferred |
Deficit
Accumulated
During the
Development |
Total
Stockholders’ |
|||||||||||||||||||||||||
Share |
Shares |
Amount |
Issued |
Capital |
Compensation |
Stage |
Deficiency |
||||||||||||||||||||||||
Balance, February 18, 1998 (date of inception) |
— |
$ |
— |
$ |
— |
$ |
— |
$ |
— |
$ |
— |
$ |
— |
||||||||||||||||||
Issuance of common stock on April 18, 1998 |
.0015 - .01 |
10,030,000 |
10,030 |
— |
14,270 |
— |
— |
24,300 |
|||||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
(21,307 |
) |
(21,307 |
) | ||||||||||||||||||||||
Balance, December 31, 1998 |
10,030,000 |
$ |
10,030 |
$ |
— |
14,270 |
$ |
— |
$ |
(21,307 |
) |
$ |
2,993 |
||||||||||||||||||
Issuance of common stock on May 18, 1999 |
1.00 - 6.40 |
198,003 |
198 |
— |
516,738 |
— |
— |
516,936 |
|||||||||||||||||||||||
Issuance of common stock for ZEFS on September 14, 1999 |
.001 |
5,000,000 |
5,000 |
— |
— |
— |
— |
5,000 |
|||||||||||||||||||||||
Stock issued for professional services on May 18, 1999 |
0.88 |
69,122 |
69 |
— |
49,444 |
— |
— |
49,513 |
|||||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
(1,075,264 |
) |
(1,075,264 |
) | ||||||||||||||||||||||
Balance, December 31, 1999 |
15,297,125 |
$ |
15,297 |
$ |
— |
$ |
580,452 |
$ |
— |
$ |
(1,096,571 |
) |
$ |
(500,822 |
) |
Price per |
Common Stock |
Common
Stock
to be |
Additional
Paid-in |
Deferred |
Deficit
Accumulated
During the
Development |
Total
Stockholders’ |
||||||||||||||||||
Share |
Shares |
Amount |
Issued |
Capital |
Compensation |
Stage |
Deficiency |
|||||||||||||||||
Balance, December 31, 1999 |
15,297,125 |
$ |
15,297 |
$ |
— |
$ |
580,452 |
$ |
— |
$ |
(1,096,571 |
) |
$ |
(500,822 |
) | |||||||||
Issuance of common stock for services |
$0.38 - $5.31 |
305,810 |
306 |
— |
588,704 |
— |
— |
589,010 |
||||||||||||||||
Stock issued for employee compensation on February 8, 2000 |
$1.03-$5.31 |
42,000 |
42 |
— |
137,378 |
— |
— |
137,420 |
||||||||||||||||
Stock issued for directors fees |
$3.38-$4.44 |
56,000 |
56 |
— |
195,584 |
— |
— |
195,640 |
||||||||||||||||
Common stock cancelled |
(55,000 |
) |
(55 |
) |
(64,245 |
) |
(64,300 |
) | ||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
(1,270,762 |
) |
(1,270,762 |
) | |||||||||||||||
Balance, December 31, 2000 |
15,645,935 |
15,646 |
— |
1,437,873 |
— |
(2,367,333 |
) |
(913,814 |
) | |||||||||||||||
Issuance of common stock for services |
$0.25-$1.65 |
1,339,912 |
1,340 |
— |
1,031,231 |
— |
— |
1,032,571 |
||||||||||||||||
Stock issued for directors fees |
$0.60-$0.95 |
1,100,000 |
1,100 |
1,008,900 |
1,010,000 |
|||||||||||||||||||
Intrinsic value of options issued to employees |
2,600,000 |
(2,600,000) |
— |
|||||||||||||||||||||
Fair value of options issued to non-employees |
142,318 |
142,318 |
||||||||||||||||||||||
Amortization of deferred compensation |
191,667 |
191,667 |
||||||||||||||||||||||
Net loss |
(2,735,013 |
) |
(2,735,013 |
) | ||||||||||||||||||||
Balance, December 31, 2001 |
18,085,847 |
$ |
18,086 |
$ |
— |
$ |
6,220,322 |
$ |
(2,408,333 |
) |
$ |
(5,102,346 |
) |
$ |
(1,272,271 |
) |
Price per |
Common Stock |
Common
Stock
to be |
Additional
Paid-in |
Deferred |
Deficit
Accumulated
During the
Development |
Total
Stockholders’ |
|||||||||||||||||||||||||
Share |
Shares |
Amount |
Issued |
Capital |
Compensation |
Stage |
Deficiency |
||||||||||||||||||||||||
Balance, December 31, 2001 |
18,085,847 |
$ |
18,086 |
$ |
— |
$ |
6,220,322 |
$ |
(2,408,333 |
) |
$ |
(5,102,346 |
) |
$ |
(1,272,271 |
) | |||||||||||||||
Stock issued for directors fees |
0.40 |
2,150,000 |
2,150 |
— |
857,850 |
— |
— |
860,000 |
|||||||||||||||||||||||
Common stock sold (2,305,000
shares) |
0.15-0.25 |
— |
— |
389,875 |
— |
— |
— |
389,875 |
|||||||||||||||||||||||
Fair value of options issued to non-employees for services |
— |
— |
— |
54,909 |
(54,909 |
) |
— |
— |
|||||||||||||||||||||||
Amortization of deferred compensation |
— |
— |
— |
— |
891,182 |
— |
891,182 |
||||||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
(2,749,199 |
) |
(2,749,199 |
) | ||||||||||||||||||||||
Balance, December 31, 2002 |
20,235,847 |
20,236 |
389,875 |
7,133,081 |
(1,572,060) |
(7,851,545 |
) |
(1,880,413 |
) | ||||||||||||||||||||||
Common stock issued previously paid for |
0.15-0.25 |
2,305,000 |
2,305 |
(433,750 |
) |
431,445 |
— |
— |
— |
||||||||||||||||||||||
Sale of common stock |
$ |
0.25 |
9,504,000 |
9,504 |
2,366,439 |
— |
— |
2,375,943 |
|||||||||||||||||||||||
Issuance of common stock for services |
$ |
0.55 |
83,414 |
83 |
— |
45,794 |
— |
— |
45,877 |
||||||||||||||||||||||
Common stock issued for convertible debt |
$ |
0.25 |
2,000,000 |
2,000 |
498,000 |
— |
— |
500,000 |
|||||||||||||||||||||||
Finders’ fees related to stock issuances |
— |
— |
43,875 |
(312,582 |
) |
— |
— |
(268,707 |
) | ||||||||||||||||||||||
Common stock
sold (25,000
shares) |
0.25 |
— |
— |
6,250 |
— |
— |
— |
6,250 |
|||||||||||||||||||||||
Amortization of deferred comp |
— |
— |
— |
— |
863,727 |
— |
863,727 |
||||||||||||||||||||||||
Net loss |
(2,476,063 |
) |
(2,476,063 |
) | |||||||||||||||||||||||||||
Balance, December 31, 2003 |
34,128,261 |
$ |
34,128 |
$ |
6,250 |
$ |
10,162,177 |
$ |
(708,333 |
) |
$ |
(10,327,608 |
) |
$ |
(833,386 |
) |
Price per |
Common Stock |
Common
Stock
to be |
Additional
Paid-in |
Deferred |
Deficit
Accumulated
During the
Development |
Total
Stockholders’ |
||||||||||||||||||||||||
Share |
Shares |
Amount |
Issued |
Capital |
Compensation |
Stage |
Deficiency |
|||||||||||||||||||||||
Balance, December 31, 2003 |
34,128,261 |
$ |
34,128 |
$ |
6,250 |
$ |
10,162,177 |
$ |
(708,333 |
) |
$ |
(10,327,608 |
) |
$ |
(833,386 |
) | ||||||||||||||
Common stock issued previously paid for |
$ |
.25 |
25,000 |
25 |
(6,250) |
6,225 |
— |
|||||||||||||||||||||||
Sale of common stock |
$ |
1.00 |
1,272,500 |
1,273 |
119,000 |
1,271,227 |
— |
— |
1,391,500 |
|||||||||||||||||||||
Stock issued for services |
$ |
.15-$1.70 |
1,268,560 |
1, |
1,268 |
1,388,663 |
1,389,931 |
|||||||||||||||||||||||
Stock issued for directors fees |
$ |
1.50 |
50,000 |
50 |
— |
74,950 |
— |
— |
75,000 |
|||||||||||||||||||||
Common stock issued for convertible debt |
$ |
1.53 |
60,000 |
60 |
91,740 |
— |
— |
91,800 |
||||||||||||||||||||||
Common stock issued upon exercise of warrants and options |
$ |
.20 -$.40 |
960,500 |
960 |
— |
193,240 |
— |
— |
194,200 |
|||||||||||||||||||||
Common stock issued for patent settlement |
$ |
1.24 |
20,000 |
20 |
24,780 |
24,800 |
||||||||||||||||||||||||
Fair value of warrants issued |
1,614,138 |
1,614,138 |
||||||||||||||||||||||||||||
Fair value of options issued to employees |
— |
— |
— |
248,891 |
(248,891 |
) |
— |
— |
||||||||||||||||||||||
Fair value of options issued to non-employees |
— |
— |
— |
55,381 |
(55,381 |
) |
— |
— |
||||||||||||||||||||||
Amortization of deferred compensation |
— |
— |
— |
— |
936,537 |
— |
936,537 |
|||||||||||||||||||||||
Finders’ fees related to stock issuances |
(88,384 |
) | ||||||||||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
(6,803,280 |
) |
(6,803,280 |
) | |||||||||||||||||||||
Balance, December 31, 2004 |
37,784,821 |
$ |
37,784 |
$ |
119,000 |
$ |
15,043,028 |
$ |
(76,068 |
) |
$ |
(17,130,888 |
) |
$ |
(2,007,144 |
) |
Price per |
Common Stock |
Common
Stock
to be |
Additional
Paid-in |
Deferred |
Deficit
Accumulated
During the
Development |
Total
Stockholders’ |
|||||||||||||||||||||
Share |
Shares |
Amount |
Issued |
Capital |
Compensation |
Stage |
Deficiency |
||||||||||||||||||||
Balance, December 31, 2004 |
37,784,821 |
$ |
37,784 |
$ |
119,000 |
$ |
15,043,028 |
$ |
(76,068 |
) |
$ |
(17,130,888 |
) |
$ |
(2,007,144 |
) | |||||||||||
Common stock issued previously paid for |
$1.00 |
119,000 |
119 |
(119,000 |
) |
118,881 |
— |
— |
— |
||||||||||||||||||
Sale of common stock |
$1.00 |
1,530,500 |
1,530 |
1,528,970 |
— |
— |
1,530,500 |
||||||||||||||||||||
Common stock issued upon exercise of warrants |
$.40 - $1.00 |
500 |
1 |
— |
199 |
— |
— |
200 |
|||||||||||||||||||
Common stock to be issued for settlement of payables |
612,521 |
612,521 |
|||||||||||||||||||||||||
Fair value of options issued for settlement costs |
31,500 |
31,500 |
|||||||||||||||||||||||||
Fair value of warrants issued |
18,462 |
18,462 |
|||||||||||||||||||||||||
Fair value of warrants issued and intrinsic value of beneficial conversion associated with convertible notes |
1,453,181 |
1,453,181 |
|||||||||||||||||||||||||
Fair value of options issued to employees |
— |
— |
— |
243,750 |
(243,750 |
) |
— |
— |
|||||||||||||||||||
Amortization of deferred compensation |
— |
— |
— |
— |
177,631 |
— |
177,631 |
||||||||||||||||||||
Finders’ fees related to stock issuances |
(109,840 |
) |
(109,840 |
) | |||||||||||||||||||||||
Common stock cancelled |
(8,047,403 |
) |
(8,047 |
) |
8,047 |
— |
|||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
(3,115,186 |
) |
(3,115,186 |
) | ||||||||||||||||||
Balance, December 31, 2005 |
31,387,418 |
$ |
31,387 |
$ |
612,521 |
$ |
18,336,178 |
$ |
(142,187 |
) |
$ |
(20,246,074 |
) |
$ |
(1,408,175 |
) |
Price per |
Common Stock |
Common
Stock
to be |
Additional
Paid-in |
Deferred |
Deficit
Accumulated
During the
Development |
Total
Stockholders’ |
|||||||||||||||||||||
Share |
Shares |
Amount |
Issued |
Capital |
Compensation |
Stage |
Deficiency |
||||||||||||||||||||
Balance, December 31, 2005 |
31,387,418 |
$ |
31,387 |
$ |
612,521 |
$ |
18,336,178 |
$ |
(142,187) |
$ |
(20,246,074 |
) |
$ |
(1,408,175 |
) | ||||||||||||
Common stock issued previously paid for |
846,549 |
847 |
(612,521 |
) |
611,674 |
— |
— |
— |
|||||||||||||||||||
Sale of common stock |
$1.00 - $1.89 |
1,360,537 |
1,360 |
60,000 |
2,401,048 |
— |
— |
2,462,408 |
|||||||||||||||||||
Common stock issued upon exercise of warrants |
$.50 - $1.50 |
2,583,533 |
2,584 |
— |
1,794,944 |
— |
— |
1,797,528 |
|||||||||||||||||||
Common stock to be issued for convertible debt |
$.70 |
3,416,186 |
3,417 |
2,356,449 |
2,359,866 |
||||||||||||||||||||||
Common stock to be issued for out of line of credit |
$.55 - $1.22 |
487,483 |
|
487 |
379,610 |
380,097 |
|||||||||||||||||||||
Fair value of options issued to employees |
— |
— |
— |
2,253,263 |
— |
2,253,263 |
|||||||||||||||||||||
Fair value of options issued for settlement costs |
31,500 |
31,500 |
|||||||||||||||||||||||||
Fair value of warrants issued for services |
463,627 |
463,627 |
|||||||||||||||||||||||||
Fair value of warrants issued and intrinsic value of beneficial conversion associated with convertible notes |
1,259.696 |
1,259,696 |
|||||||||||||||||||||||||
Write off of deferred compensation |
— |
— |
— |
(142,187 |
) |
142,187 |
— |
— |
|||||||||||||||||||
Finders’ fees related to stock issuances |
(284,579 |
) |
(284,579 |
) | |||||||||||||||||||||||
Fees paid on equity line of credit |
(30,402 |
) |
(30,402 |
) | |||||||||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
(10,181,523 |
) |
(10,181,523 |
) | ||||||||||||||||||
Balance, December 31, 2006 |
40,081,757 |
$ |
40,082 |
$ |
60,000 |
$ |
29,430,821 |
$ |
— |
$ |
(30,427,597 |
) |
$ |
(896,694 |
) |
Price per |
Common Stock |
Common
Stock
to be |
Additional
Paid-in |
Deficit
Accumulated
During the
Development |
Total
Stockholders’ |
||||||||||||||||||||
Share |
Shares |
Amount |
Issued |
Capital |
Stage |
Deficiency |
|||||||||||||||||||
Balance, December 31, 2006 |
40,081,757 |
$ |
40,082 |
$ |
60,000 |
$ |
29,430,821 |
$ |
(30,427,597 |
) |
$ |
(896,694 |
) | ||||||||||||
Common stock issued previously paid for |
2,597,524 |
2,598 |
(60,000 |
) |
57,402 |
— |
— |
||||||||||||||||||
Common stock to be issued for convertible debt |
$.17 - $.53 |
1,910,711 |
1,911 |
524,569 |
526,480 |
||||||||||||||||||||
Common stock issued for put of line of credit |
$.27 - $.73 |
1,880,421 |
1,880 |
990,175 |
992,055 |
||||||||||||||||||||
Common stock granted for services |
4,000 |
4,000 |
|||||||||||||||||||||||
Fair value of options issued to employees |
— |
— |
— |
67,592 |
— |
67,592 |
|||||||||||||||||||
Fair value of warrants issued for services |
35,340 |
35,340 |
|||||||||||||||||||||||
Fair value of warrants issued and intrinsic value of beneficial conversion associated with convertible notes |
1,253,548 |
1,253,548 |
|||||||||||||||||||||||
Fees paid on equity line of credit |
(79,364 |
) |
(79,364 |
) | |||||||||||||||||||||
Net loss |
— |
— |
— |
— |
(6,262,743 |
) |
(6,262,743 |
) | |||||||||||||||||
Balance, December 31, 2007 |
46,470,413 |
$ |
46,471 |
$ |
4,000 |
$ |
32,280,083 |
$ |
(36,690,340 |
) |
$ |
(4,359,786 |
) |
Price per |
Common Stock |
Common
Stock
to be |
Additional
Paid-in |
Deficit
Accumulated
During the
Development |
Total
Stockholders’ |
||||||||||||||||||||
Share |
Shares |
Amount |
Issued |
Capital |
Stage |
Deficiency |
|||||||||||||||||||
Balance, December 31, 2007 |
46,470,413 |
$ |
46,471 |
$ |
4,000 |
$ |
32,280,083 |
$ |
(36,690,340 |
) |
$ |
(4,359,786 |
) | ||||||||||||
Common stock issued for convertible debt |
$.17 - $.53 |
5,575,082 |
5,574 |
16,500 |
1,936,171 |
— |
1,958,245 |
||||||||||||||||||
Common stock issued for Morale/ Matthews settlement |
$.38 |
7,421,896 |
7,422 |
— |
2,776,289 |
— |
2,783,711 |
||||||||||||||||||
Common stock issued for services |
$.17 - $.49 |
2,398,850 |
2,399 |
— |
516,230 |
— |
518,629 |
||||||||||||||||||
Common stock issued upon exercise of warrants |
$.50 |
1,064,650 |
1,065 |
— |
531,260 |
— |
532,325 |
||||||||||||||||||
Fair value of options issued as compensations |
— |
— |
— |
— |
645,745 |
— |
645,745 |
||||||||||||||||||
Fair value of warrants issued and intrinsic value of beneficial conversion associated with convertible notes |
— |
— |
— |
— |
1,323,077 |
— |
1,323,077 |
||||||||||||||||||
Fair value of warrants issued to PIPE holders |
— |
— |
— |
— |
116,913 |
— |
116,913 |
||||||||||||||||||
Common stock issued for services |
0.17 |
10,000 |
10 |
(4,000 |
) |
3,990 |
— |
— |
|||||||||||||||||
Net loss |
— |
— |
— |
— |
— |
(6,052,724 |
) |
(6,052,724 |
|||||||||||||||||
Balance, December 31, 2008 |
62,940,891 |
$ |
62,941 |
$ |
16,500 |
$ |
40,129,758 |
$ |
(42,743,064 |
) |
$ |
(2,533,865 |
) |
Price per |
Common Stock |
Common Stock to be |
Additional
Paid-in |
Deficit Accumulated During the Development |
Total
Stockholders’ |
|||||||||||||||||||||||
Share |
Shares |
Amount |
Issued |
Capital |
Stage |
Deficiency |
||||||||||||||||||||||
Balance, December 31, 2008 |
62,940,891 | $ | 62,941 | $ | 16,500 | $ | 40,129,758 | $ | (42,743,064 | ) | $ | (2,533,865 | ) | |||||||||||||||
Common stock issued for convertible debt |
0.15-0.50 | 2,014,914 | 2,015 | (16,500 | ) | 430,614 | — | 416,129 | ||||||||||||||||||||
Common stock issued for services |
0.17-0.49 | 502,355 | 502 | — | 173,911 | — | 174,413 | |||||||||||||||||||||
Common stock issued for settlement of accounts payable |
0.27 | 50,000 | 50 | 33,750 | 13,450 | — | 47,250 | |||||||||||||||||||||
Fair value of options issued as compensation |
— | — | — | — | 44,498 | — | 44,498 | |||||||||||||||||||||
Fair value of warrants issued for note payable |
— | — | — | — | 1,248 | — | 1,248 | |||||||||||||||||||||
Fair value of warrants issued and intrinsic value of beneficial conversion associated with convertible notes |
— | — | — | — | 534,663 | — | 534,663 | |||||||||||||||||||||
Net loss |
— | — | — | — | — | (2,531,762 | ) | (2,531,762 | ) | |||||||||||||||||||
Balance, June 30, 2009 (unaudited) |
65,508,160 | $ | 65,508 | $ | 33,750 | 41,328,142 | $ | (45,274,826 | ) | $ | (3,847,426 | ) |
Six months ended |
February 18, 1998 |
|||||||||||
June 30, |
June 30, |
(inception) |
||||||||||
2009 |
2008 |
To June 30, 2009 |
||||||||||
Cash flows from operating activities |
||||||||||||
Net loss |
$ |
(2,531,762 |
) |
$ |
(2,975,874 |
) |
$ |
(45,274,826 |
) | |||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||||||
Write off of intangible assets |
— |
— |
505,000 |
|||||||||
Settlement of litigation and debt |
— |
— |
(1,017,208 |
) | ||||||||
Settlement of debt due Morale/Matthews |
— |
927,903 |
927,903 |
|||||||||
Stock based compensation expense |
45,746 |
43,636 |
3,660,667 |
|||||||||
Issuance of common stock for services |
174,413 |
51,879 |
5,378,644 |
|||||||||
Issuance of options for legal settlement |
— |
— |
31,500 |
|||||||||
Issuance of warrants for legal settlement |
— |
— |
4,957 |
|||||||||
Issuance of warrants for financing fees |
— |
116,913 |
152,253 |
|||||||||
Non-cash increase in convertible notes recorded as expense |
— |
89,470 |
163,962 |
|||||||||
Patent acquisition cost |
— |
— |
1,610,066 |
|||||||||
Addition of Interest Expense to Convertible Note Principal |
23,000 |
— |
23,000 |
|||||||||
Amortization of issuance costs and original issue debt discounts including beneficial conversion feature-part of interest expense |
797,457 |
514,942 |
6,415,766 |
|||||||||
Amortization of deferred compensation |
— |
— |
3,060,744 |
|||||||||
Loss on disposition of assets |
— |
9,683 |
14,426 |
|||||||||
Depreciation and amortization |
16,776 |
19,447 |
409,905 |
|||||||||
Bad debt |
— |
1,380 |
1,380 |
|||||||||
Changes in operating assets and liabilities: |
||||||||||||
Accounts receivable |
— |
— |
(1,380 |
) | ||||||||
Inventory |
— |
— |
— |
|||||||||
Prepaid expenses and other |
10,228 |
(15,870 |
) |
(23,047 |
) | |||||||
Other assets |
230 |
(6,750 |
) |
(11,020 |
) | |||||||
Accounts payable and accrued expenses |
610,880 |
167,869 |
4,298,491 |
|||||||||
Net cash used in operating activities |
(853,032 |
) |
(1,055,372 |
) |
(19,668,817 |
) | ||||||
Cash flows from investing activities |
||||||||||||
Purchase of property and equipment |
— |
(345 |
) |
(553,452 |
) | |||||||
Proceeds from sale of equipment |
— |
17,477 |
17,478 |
|||||||||
Net cash provided by (used in) investing activities |
— |
17,132 |
(535,974 |
) | ||||||||
Cash flows from financing activities |
||||||||||||
Net proceeds under equity line of credit |
— |
— |
1,262,386 |
|||||||||
Increase (decrease) in payables to related parties and shareholder |
84,061 |
2,442 |
694,125 |
|||||||||
Advances from founding executive officer |
— |
— |
517,208 |
|||||||||
Net proceeds from issuance of convertible notes and warrants |
714,820 |
534,000 |
7,175,243 |
|||||||||
Repayment of convertible notes |
— |
— |
(226,250 |
) | ||||||||
Net proceeds from issuance of common stock |
— |
532,325 |
10,787,274 |
|||||||||
Net cash provided by financing activities |
798,881 |
1,068,767 |
20,209,986 |
|||||||||
Net increase (decrease) in cash |
(54,151 |
) |
30,527 |
5,195 |
||||||||
Cash, beginning of period |
59,346 |
47,660 |
— |
|||||||||
Cash, end of period |
$ |
5,195 |
$ |
78,187 |
$ |
5,195 |
Six months ended |
February 18, 1998 |
|||||||||||
June 30, |
June 30, |
(inception) to |
||||||||||
2009 |
2008 |
June 30, 2009 |
||||||||||
Supplemental disclosures of cash flow information |
||||||||||||
Cash paid during the period for |
||||||||||||
Interest |
$ |
1,584 |
$ 621 |
$ |
137,983 |
|||||||
Income taxes |
$ |
— |
$ |
— |
$ |
5,882 |
||||||
Non-cash investing and financing activities |
||||||||||||
Acquisition of intangible asset through advance from related party and issuance of common stock |
$ |
— |
$ |
— |